Were waiting to hear from you
COA / Lab results Evidence: Preclinical Pros Studied for tendon, ligament, muscle and bone repair Angiogenic and gut-protective action in animal models Stable in gastric juice, unlike many growth-factor peptides Commonly paired with TB-500 in recovery protocols Cons Evidence is preclinical animal/in-vitro only, no human trials Human efficacy and dosing unestablished Pros and cons summarise available published data from peer-reviewed studies
TB-4: cell migration Full-length thymosin beta-4 (43 amino acids) governs how repair cells move into tissue and organize once they arrive (G-actin sequestration). It biases healing toward functional tissue over rope-like scarring (Ac-SDKP anti-fibrotic signaling) and helps inflammation resolve cleanly. KLOW uses the full-length parent, not the shorter TB-500 fragment
Measuring further away from the inflamed bone surface, we detected no difference in bone volume in alveolar bone spongiosa between the control vs
In the above studies on rare diseases, much lower doses were used, and increased doses may improve clinical outcomes in future studies
insert the needle at 4590 into subcutaneous tissue [8] [10]
.webp)
